SG11201506800YA - Bicyclo [2.2.2] acid gpr120 modulators - Google Patents
Bicyclo [2.2.2] acid gpr120 modulatorsInfo
- Publication number
- SG11201506800YA SG11201506800YA SG11201506800YA SG11201506800YA SG11201506800YA SG 11201506800Y A SG11201506800Y A SG 11201506800YA SG 11201506800Y A SG11201506800Y A SG 11201506800YA SG 11201506800Y A SG11201506800Y A SG 11201506800YA SG 11201506800Y A SG11201506800Y A SG 11201506800YA
- Authority
- SG
- Singapore
- Prior art keywords
- bicyclo
- gpr120 modulators
- acid
- acid gpr120
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361782396P | 2013-03-14 | 2013-03-14 | |
| PCT/US2014/025187 WO2014159802A1 (en) | 2013-03-14 | 2014-03-13 | Bicyclo [2.2.2] acid gpr120 modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201506800YA true SG11201506800YA (en) | 2015-09-29 |
Family
ID=50639933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201506800YA SG11201506800YA (en) | 2013-03-14 | 2014-03-13 | Bicyclo [2.2.2] acid gpr120 modulators |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9598390B2 (he) |
| EP (1) | EP2970172B1 (he) |
| JP (1) | JP2016516708A (he) |
| KR (1) | KR20150130398A (he) |
| CN (1) | CN105209447B (he) |
| AU (1) | AU2014244482B2 (he) |
| BR (1) | BR112015021386A2 (he) |
| CA (1) | CA2905431A1 (he) |
| EA (1) | EA201591815A1 (he) |
| ES (1) | ES2765973T3 (he) |
| IL (1) | IL241318B (he) |
| MX (1) | MX366820B (he) |
| SG (1) | SG11201506800YA (he) |
| WO (1) | WO2014159802A1 (he) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3191445B1 (en) | 2014-09-09 | 2019-06-12 | Bristol-Myers Squibb Company | Cyclobutane containing carboxylic acid gpr120 modulators |
| WO2016040225A1 (en) | 2014-09-09 | 2016-03-17 | Bristol-Myers Squibb Company | Phenyl-(aza)cycloalkyl carboxylic acid gpr120 modulators |
| WO2016040222A1 (en) | 2014-09-09 | 2016-03-17 | Bristol-Myers Squibb Company | Cyclopropanecarboxylic acid gpr120 modulators |
| US10954233B2 (en) | 2016-09-09 | 2021-03-23 | Novartis Ag | Compounds and compositions as inhibitors of endosomal toll-like receptors |
| EP3529230B1 (en) | 2016-10-19 | 2020-09-30 | Eastman Chemical Company | Synthesis of bicyclo(2.2.2)octanes |
| JP7136807B2 (ja) | 2017-04-17 | 2022-09-13 | ザ・ユニバーシティ・オブ・シカゴ | ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料 |
| WO2019075004A1 (en) | 2017-10-11 | 2019-04-18 | Eastman Chemical Company | SYNTHESIS OF BICYCLO [2.2.2] OCTANE DERIVATIVES |
| KR20200081434A (ko) | 2017-11-01 | 2020-07-07 | 브리스톨-마이어스 스큅 컴퍼니 | 파르네소이드 x 수용체 조정제로서의 가교된 비시클릭 화합물 |
| EP3765446A1 (en) | 2018-03-15 | 2021-01-20 | AXXAM S.p.A. | Substituted pyrazoles ffa4/gpr120 receptor agonists |
| US10836899B2 (en) | 2018-12-13 | 2020-11-17 | Eastman Chemical Company | Polyesters with specified crystallization half-times |
| CN114585629B (zh) | 2019-11-06 | 2024-10-01 | 伊士曼化工公司 | 制备双环[2.2.2]辛烷-1,4-二醇的方法 |
| CN113248438B (zh) * | 2021-05-17 | 2022-04-12 | 浙大城市学院 | 一种吡唑类化合物及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614492A (en) | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| US6008234A (en) * | 1996-09-12 | 1999-12-28 | Berlex Laboratories, Inc. | Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants |
| CZ20021614A3 (cs) * | 1999-11-12 | 2002-07-17 | Biogen, Inc. | Polycykloalkylpuriny jako antagonisty adenosinového receptoru |
| UA80258C2 (en) * | 2001-09-06 | 2007-09-10 | Biogen Inc | Methods of treating pulmonary disease |
| EP1513848A4 (en) * | 2002-06-12 | 2005-11-09 | Biogen Idec Inc | METHOD FOR TREATING ISCHEMIA REPERFUSION INJURIES WITH ADENOSINE RECEPTOR ANTAGONISTS |
| US7754757B2 (en) * | 2004-02-05 | 2010-07-13 | Kyorin Pharmaceutical Co., Ltd. | Bicycloester derivative |
| US7749997B2 (en) * | 2005-12-22 | 2010-07-06 | Astrazeneca Ab | Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors |
| ATE490243T1 (de) * | 2006-12-27 | 2010-12-15 | Sanofi Aventis | Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate |
| EP2367822B1 (en) * | 2008-12-18 | 2016-10-05 | Merck Patent GmbH | Tricyclic azaindoles |
| JPWO2012124744A1 (ja) | 2011-03-14 | 2014-07-24 | 大正製薬株式会社 | 含窒素縮合複素環化合物 |
| WO2013068328A1 (en) * | 2011-11-07 | 2013-05-16 | Intervet International B.V. | Bicyclo [2.2.2] octan-1-ylcarboxylic acid compounds as dgat-1 inhibitors |
| WO2013074387A1 (en) * | 2011-11-14 | 2013-05-23 | Merck Sharp & Dohme Corp. | Imidazole derivatives |
| US8962660B2 (en) | 2013-03-14 | 2015-02-24 | Bristol-Myers Squibb Company | Oxabicyclo [2.2.2] acid GPR120 modulators |
-
2014
- 2014-03-13 JP JP2016501778A patent/JP2016516708A/ja active Pending
- 2014-03-13 CN CN201480028180.2A patent/CN105209447B/zh not_active Expired - Fee Related
- 2014-03-13 WO PCT/US2014/025187 patent/WO2014159802A1/en active Application Filing
- 2014-03-13 MX MX2015011932A patent/MX366820B/es active IP Right Grant
- 2014-03-13 EP EP14721602.2A patent/EP2970172B1/en active Active
- 2014-03-13 SG SG11201506800YA patent/SG11201506800YA/en unknown
- 2014-03-13 KR KR1020157027941A patent/KR20150130398A/ko not_active Application Discontinuation
- 2014-03-13 BR BR112015021386A patent/BR112015021386A2/pt not_active IP Right Cessation
- 2014-03-13 CA CA2905431A patent/CA2905431A1/en not_active Abandoned
- 2014-03-13 AU AU2014244482A patent/AU2014244482B2/en not_active Ceased
- 2014-03-13 EA EA201591815A patent/EA201591815A1/ru unknown
- 2014-03-13 ES ES14721602T patent/ES2765973T3/es active Active
- 2014-03-13 US US14/774,276 patent/US9598390B2/en active Active
-
2015
- 2015-09-08 IL IL241318A patent/IL241318B/he active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX366820B (es) | 2019-07-25 |
| AU2014244482B2 (en) | 2018-01-25 |
| US9598390B2 (en) | 2017-03-21 |
| CA2905431A1 (en) | 2014-10-02 |
| BR112015021386A2 (pt) | 2017-07-18 |
| KR20150130398A (ko) | 2015-11-23 |
| CN105209447A (zh) | 2015-12-30 |
| EP2970172B1 (en) | 2019-10-30 |
| US20160039780A1 (en) | 2016-02-11 |
| CN105209447B (zh) | 2017-11-21 |
| ES2765973T3 (es) | 2020-06-11 |
| JP2016516708A (ja) | 2016-06-09 |
| IL241318A0 (he) | 2015-11-30 |
| IL241318B (he) | 2018-12-31 |
| WO2014159802A1 (en) | 2014-10-02 |
| MX2015011932A (es) | 2015-12-01 |
| AU2014244482A1 (en) | 2015-11-05 |
| EA201591815A1 (ru) | 2016-01-29 |
| EP2970172A1 (en) | 2016-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL241323A0 (he) | מאפננים של חומצה אוקסביציקלו [2,22,] 120gpr | |
| IL241318A0 (he) | חומצת ביציקלו[2.2.1] כמודולטורים של 120gpr | |
| EP3060118A4 (en) | Motion monitor | |
| EP3076241A4 (en) | Ultraviolet-ray-curable liquid developer | |
| IL241245A0 (he) | חומצת ביציקלו [2.2.1] כמודולטורים של gpr120 | |
| EP3052015A4 (en) | Detachable electrocardiography device | |
| GB201302863D0 (en) | The Instaponytail | |
| EP3060553A4 (en) | Novel compounds | |
| EP3088959A4 (en) | Liquid developer | |
| GB201312513D0 (en) | 2 4 1 Technology | |
| AU2013903009A0 (en) | Safegrip 2 | |
| EP3088251A4 (en) | CHARACTER VIEW PLATE | |
| AU2013903776A0 (en) | The mungrill | |
| AU2013902525A0 (en) | The strap-trap | |
| AU2014276609A1 (en) | Agitator assembly | |
| AU2013900524A0 (en) | The waterwatch | |
| AU2013903782A0 (en) | 400 Series De-Awner | |
| AU2013902343A0 (en) | Fertilizer | |
| AU2013904815A0 (en) | Structured globules | |
| AU2012904225A0 (en) | 28.8Scanfit | |
| AU2013904379A0 (en) | Improved Objects Type 5 | |
| AU2013904222A0 (en) | Type 24 Vehicles | |
| AU2013902960A0 (en) | Planting | |
| AU2013903799A0 (en) | Type 23 Vehicles | |
| AU2012901213A0 (en) | 28.8trackside |